The CR failure of OBJ was the last nail in the coffin.
Shareholder update was not a good read, Southoz summed it up quite nicely.
I have moved my main funds away from PNO for a while now but sold the last trading parcel, I did still hold, some days ago.
OBJ can not come to rescue, it is busy rescuing itself, so it seems.
Legal costs concerning Novus best be avoided, but that means that there will be not much additional money in the kitty as many shareholders might want their money back from the failed CR.
This would stall our own product developments.
Overall, both companies lack transparency, enticing outlook and I'm in the process of thinning out my holdings in the sister company as well.
For me personally, June will mark the end of my investment in OBJ should material news not appear.
- Forums
- ASX - By Stock
- biotechs in resurgence
The CR failure of OBJ was the last nail in the coffin....
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAI (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CAI (ASX) Chart |
Day chart unavailable
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online